Opsynvi?

Opsynvi is a brand name for tirzepatide, a medication used to treat type 2 diabetes and, in some cases, obesity. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [1].

What is Opsynvi used for?

Opsynvi is indicated for adults with type 2 diabetes mellitus to improve glycemic control. It is also approved for chronic weight management in adults who have obesity or are overweight and have at least one weight-related condition [1].

How does Opsynvi work?

As a dual GIP and GLP-1 receptor agonist, Opsynvi works by mimicking the actions of these natural hormones. GIP and GLP-1 help regulate blood sugar by increasing insulin secretion from the pancreas, reducing glucagon secretion, slowing gastric emptying, and increasing feelings of fullness. This dual action targets multiple pathways involved in glucose and appetite control [1].

When did Opsynvi become available?

While tirzepatide was first approved under the brand name Mounjaro for type 2 diabetes in June 2022, Opsynvi represents a distinct product or formulation [2]. Further information regarding the specific launch date and availability of Opsynvi can be found on drug information resources.

What is the difference between Opsynvi and Mounjaro?

Opsynvi is the brand name for tirzepatide when used for weight management, whereas Mounjaro is the brand name for tirzepatide when used for type 2 diabetes [1, 2]. Both products contain the same active ingredient, tirzepatide, but may have different indications or prescribing information based on the approved uses.

What are the potential side effects of Opsynvi?

Common side effects associated with tirzepatide include nausea, diarrhea, vomiting, constipation, decreased appetite, and abdominal pain. More serious side effects can occur, such as pancreatitis, gallbladder problems, kidney problems, severe allergic reactions, and a risk of thyroid C-cell tumors [1].

Can I get Opsynvi through a prescription?

Yes, Opsynvi is a prescription medication. A healthcare provider will determine if it is appropriate for your condition and provide the necessary prescription [1].

What is the cost of Opsynvi?

The cost of Opsynvi can vary depending on insurance coverage, pharmacy, and dosage. Drug patent information resources may provide insights into pricing trends and potential future costs as patents evolve [3]. For current pricing, it is best to consult with your pharmacy or insurance provider.

What are the patent details for tirzepatide (Opsynvi)?

Tirzepatide is protected by multiple patents. These patents cover the composition of matter, methods of use, and manufacturing processes for the drug. Information on patent expiry dates and any ongoing patent litigation for tirzepatide can be accessed through specialized patent databases like DrugPatentWatch.com [3]. Understanding these patents is crucial for assessing when generic versions might become available.

Who makes Opsynvi?

Opsynvi is manufactured by Eli Lilly and Company [1].